Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: A randomized study

Clinical Breast Cancer

Volumn 12, Issue 3, 2012, Pages 175-182

  Campagnoli, Carlo ^a   Pasanisi, Patrizia ^b   Abbà, Chiara ^a   Ambroggio, Simona ^a   Biglia, Nicoletta ^c   Brucato, Tiziana ^a   Colombero, Raffaella ^a   Danese, Saverio ^d   Donadio, Michela ^d   Venturelli, Elisabetta ^b   Zito, Gianna ^a   Berrino, Franco ^b  

^a Azienda Ospedaliera OIRM sant'Anna Torino   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Azienda Ospedaliera Universitaria San Giovanni Battista di Torino   (Italy)

Author keywords

Breast cancer; Insulin; Metformin; Randomized trial; Testosterone

Indexed keywords

INSULIN; METFORMIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL DISEASE; HOMEOSTASIS MODEL ASSESSMENT INSULIN RESISTANCE INDEX; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL;

EID: 84861155928     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2012.03.004     Document Type: Article

References (46)

1. C. Agnoli, F. Berrino, C.A. Abagnato Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study Nutr Metab Cardiovasc Dis 20 2010 41 48
2. P. Pasanisi, F. Berrino, M. De Petris Metabolic syndrome as a prognostic factor for breast cancer recurrences Int J Cancer 119 2006 236 238
3. P.J. Goodwin, M. Ennis, K.I. Pritchard Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study J Clin Oncol 20 2002 42 51
4. M.J. Gunter, D.R. Hoover, H. Yu Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women J Natl Cancer Inst 101 2009 48 60
5. F. Berrino, P. Pasanisi, C. Bellati Serum testosterone levels and breast cancer recurrence Int J Cancer 113 2005 499 502
6. J.A. Emond, R.E. Patterson, L. Natarajan Sex hormone concentrations and the risk of breast cancer recurrence in postmenopausal women without hot flashes Cancer Epidemiol Biomarkers Prev 20 2011 939 945
7. G.N. Farhat, S.R. Cummings, R.T. Chlebowski Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers J Natl Cancer Inst 103 2011 562 570
8. S.E. Hankinson, A.H. Eliassen Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk J Steroid Biochem Mol Biol 106 2007 24 30
9. R.E. James, A. Lukanova, L. Dossus Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study Cancer Prev Res (Phila) 4 2011 1626 1635
10. A. Micheli, E. Meneghini, G. Secreto Plasma testosterone and prognosis of postmenopausal breast cancer patients J Clin Oncol 25 2007 2685 2690
11. L.M. Berstein Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer Cancer Lett 224 2005 203 212
12. J. McCormack, K. Johns, H. Tildesley Metformin's contraindications should be contraindicated CMAJ 173 2005 502 504
13. E. Giovannucci, D.M. Harlan, M.C. Archer Diabetes and cancer: a consensus report CA Cancer J Clin 60 2010 207 221
14. A. Decensi, M. Puntoni, P. Goodwin Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis Cancer Prev Res (Phila) 3 2010 1451 1461
15. M.S. Lee, C.C. Hsu, M.L. Wahlqvist Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals BMC Cancer 11 2011 20
16. M. Monami, C. Colombi, D. Balzi Metformin and cancer occurrence in insulin-treated type 2 diabetic patients Diabetes Care 34 2011 129 131
17. M. Bodmer, C. Meier, S. Krähenbühl Long-term metformin use is associated with decreased risk of breast cancer Diabetes Care 33 2010 1304 1308
18. J.L. Bosco, S. Antonsen, H.T. Sorensen Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark Cancer Epidemiol Biomarkers Prev 20 2011 101 111
19. S. Jiralerspong, S.L. Palla, S.H. Giordano Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer J Clin Oncol 27 2009 3297 3302
20. A. Vazquez-Martin, C. Oliveras-Ferraros, S. Cufí Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells Curr Mol Med 10 2010 674 691
21. A. Belfiore, F. Frasca, G. Pandini Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease Endocr Rev 30 2009 586 623
22. J.E. Nestler Metformin for the treatment of the polycystic ovary syndrome N Engl J Med 358 2008 47 54
23. S. Palomba, A. Falbo, F. Zullo Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review Endocr Rev 30 2009 1 50
24. S.M. Patel, N. Iqbal, S. Kaul Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial Fertil Steril 94 2010 2161 2166
25. A.M. Gonzalez-Angulo, F. Meric-Bernstam Metformin: a therapeutic opportunity in breast cancer Clin Cancer Res 16 2010 1695 1700
26. P.J. Goodwin, V. Stambolic, J. Lemieux Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents Breast Cancer Res Treat 126 2011 215 220
27. P. Muti, F. Berrino, V. Krogh Metformin, diet and breast cancer: an avenue for chemoprevention Cell Cycle 8 2009 2661
28. S. Hadad, T. Iwamoto, L. Jordan Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial Breast Cancer Res Treat 128 2011 783 794
29. B. Martin-Castillo, J. Dorca, A. Vazquez-Martin Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical-translational research experience at the Catalan Institute of Oncology Ann Oncol 21 2010 187 189
30. L. Morin-Papunen, I. Vauhkonen, R. Koivunen Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study J Clin Endocrinol Metab 88 2003 148 156
31. S. Tan, S. Hahn, S. Benson Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance Eur J Endocrinol 157 2007 669 676
32. E. Rossi, A. Morabito, F. Di Rella Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial J Clin Oncol 27 2009 3192 3197
33. G. Bolelli, P. Muti, A. Micheli Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma Cancer Epidemiol Biomarkers Prev 4 1995 509 513
34. D.R. Matthews, J.P. Hosker, A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
35. C. Duggan, M.L. Irwin, L. Xiao Associations of insulin resistance and adiponectin with mortality in women with breast cancer J Clin Oncol 29 2011 32 39
36. P.J. Goodwin, K.I. Pritchard, M. Ennis Insulin-lowering effects of metformin in women with early breast cancer Clin Breast Cancer 8 2008 501 505
37. M. Pollak Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 2008 915 928
38. B. Martin-Castillo, A. Vazquez-Martin, C. Oliveras-Ferraros Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena Cell Cycle 9 2010 1057 1064
39. H.A. Hirsch, D. Iliopoulos, P.N. Tsichlis Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission Cancer Res 69 2009 7507 7511
40. M. Pollak Metformin and other biguanides in oncology: advancing the research agenda Cancer Prev Res (Phila) 3 2010 1060 1065
41. M. Cazzaniga, B. Bonanni, A. Guerrieri-Gonzaga Is it time to test metformin in breast cancer clinical trials? Cancer Epidemiol Biomarkers Prev 18 2009 701 705
42. P. Pasanisi, A. Villarini, M. Raimondi Nutritional advice to breast cancer survivors Supp Care Cancer 18 2010 29 33
43. S.M. Patel, S.J. Ratcliffe, M.P. Reilly Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease J Clin Endocrinol Metab 94 2009 4776 4784
44. C. Dimitrakakis, C. Bondy Androgens and the breast Breast Cancer Res 11 2009 212
45. M. Ni, Y. Chen, E. Lim Targeting androgen receptor in estrogen receptor-negative breast cancer Cancer Cell 20 2011 119 131
46. M. Barba, H.J. Schünemann, F. Sperati The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis Clin Endocrinol Oxf 70 2009 661 670